| 常用名 | Bioymifi | CAS号 | 1420071-30-2 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 需询单 | 库存 | 需询单 |
| 产品详情(用途,包装等)
用途: Bioymifi(DR5 Activator) is the first novel and potent small-molecule activatior of the TRAIL receptor DR5 in human cancer cells.IC50 value:Target: In comparison with A2C2, bioymifi was able to promote cell death without the need for the Smac mimetic in T98G cells. Notably, at a 10-μM concentration, bioymifi induced processing of caspase-3 into smaller fragments. Z-VAD inhibited these caspase-mediated cleavages. caspase-3 was rapidly activated as early as 2 h after bioymifi treatment of T98G cells. The caspase-3 activity was markedly increased after 8 h of treatment. Bioymifi induces caspase-8–dependent apoptosis. 物理化学性质: CAS号:1420071-30-2 常用中文名:Bioymifi 常用英文名:Bioymifi 分子式:C22H12BrN3O4S 分子量:494.317 密度:1.8±0.1 g/cm3 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:-20℃ |